Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 I have observed, via Net research, that there has been a lot of recent interest from American, European, and Australian pharmaceutical companies in one particular component of rudraksham. I keep seing seminar announcements, but no documentation of proccedings (of course <g>). Also, references to experiments are posted, but not the experiments. I am also seeing a lot of stuff re: enhanced conservation efforts toward various elaeocarpacaea varieties, in various parts of the world. I'm wondering if the two are connected? In any case, attention by major pharmaceutical companies might turn out to be GOOD news, because it would focus interest on the beads, and might possibly benefit the bead industries. Since the drug companies are experimenting with synthetic derivatives, the drug companies wouldn't be depleting the supply. It would also focus attention on the Asian medicinal arts Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 Kari wrote: "...I am also seeing a lot of stuff re: enhanced conservation efforts toward various elaeocarpacaea varieties, in various parts of the world. I'm wondering if the two are connected?..." Could you be more specific? Where are you "seeing" these reports on conservation efforts? I was under the impression that overharvesting was more the norm. "...In any case, attention by major pharmaceutical companies might turn out to be GOOD news, because it would focus interest on the beads, and might possibly benefit the bead industries. Since the drug companies are experimenting with synthetic derivatives, the drug companies wouldn't be depleting the supply. It would also focus attention on the Asian medicinal arts." It sure will be good news for the multinationals. However if people start paying more attention to the asian medicinal arts(i like that phrase:-))pharmazillas might go broke. I just hope your statement that they will be experimenting with synthetic derivatives is true. Time will tell. Suraj Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 The impact of World Trade Organisation (WTO) and intellectual property rights (IPR) on traditional systems of medicine and the unregulated exploitation of medicinal plants was brought up last year in the world media (see a few links below for details), but what has happened since last year, does anyone know? http://news.indiainfo.com/2002/10/31/31ayurveda.html http://www.ayurvedahc.com/Library/AyurvedaCopyright.htm http://www.vshiva.net/archives/biopiracy/protect_biodiversity.htm Love, Ole , "karisprowl" <karisprowl@e...> wrote: > I have observed, via Net research, that there has been a lot of recent > interest from American, European, and Australian pharmaceutical > companies in one particular component of rudraksham. I keep seing > seminar announcements, but no documentation of proccedings (of course > <g>). Also, references to experiments are posted, but not the > experiments. > > I am also seeing a lot of stuff re: enhanced conservation efforts > toward various elaeocarpacaea varieties, in various parts of the > world. > > I'm wondering if the two are connected? > > In any case, attention by major pharmaceutical companies might turn > out to be GOOD news, because it would focus interest on the beads, and > might possibly benefit the bead industries. Since the drug companies > are experimenting with synthetic derivatives, the drug companies > wouldn't be depleting the supply. It would also focus attention on the > Asian medicinal arts Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 Ole: I haven't kept up with it but there was an initiative in India to set up the Traditional Knowledge Digital Initiative(you might look for more info on the web or some specialised databases) for classical Ayurvedic and Siddha formulations to prevent abuse by big corporations. I believe in TCM, there are patents on classical formulations but since it is too expensive for developing countries and too time consuming to file for patents( Ayurveda alone has over 35,000 classical formulations)in India the folks have decided to make the knowledge public, sort of like open source software. I'd like to keep up on the developments myself. Thanks for giving me a project for the coming weeks:-) Happy Diwali Suraj Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 I found a lot of conservation references, accidentally, when I was trying to research ethnomedical and ethnobotanical applications of elaeocarpacaea. Yes, overharvesting HAS been the norm, but apparantly that has come to some folks' attention in a few countries (Australia, for one-- with the quadongs). I don't know what the impetus is, but there are conservation efforts, and in several countries. I dis not save the references, unfortunatley, because my focus was on other things. I also learned that experimentation has been on a synthetic derivative (I don't remember the name of the chemical) of rudraksham from reading the experimental references, what few absracts there are, and the seminar programs. Agree with you re: your opinion on corporate greed. However, if a plant could be patented, one would think that the heart med plants would be first choice-- at least in the U.S. Or, maybe ephedra-- one of the top moneymaking pharmaceuticals in the U.S. is Claritin, an allergy medication. Moreover, if one can isolate and synthesize a chemical, like the one in the humble periwinkle, that destroys cancer cells, one doesn't need the plant, itself. There is no valerian in Valium. <g> K. , "surajraghavan2002" <suraj_raghavan@h...> wrote: > Kari wrote: > "...I am also seeing a lot of stuff re: enhanced conservation > efforts > toward various elaeocarpacaea varieties, in various parts of the > world. > > I'm wondering if the two are connected?..." > > Could you be more specific? Where are you "seeing" these reports on > conservation efforts? I was under the impression that overharvesting > was more the norm. > > "...In any case, attention by major pharmaceutical companies might > turn > out to be GOOD news, because it would focus interest on the beads, > and might possibly benefit the bead industries. Since the drug > companies are experimenting with synthetic derivatives, the drug > companies wouldn't be depleting the supply. It would also focus > attention on the Asian medicinal arts." > > It sure will be good news for the multinationals. However if people > start paying more attention to the asian medicinal arts(i like that > phrase:-))pharmazillas might go broke. I just hope your statement > that they will be experimenting with synthetic derivatives is true. > Time Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.